AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
Selling, General & Administrative
AxoGen Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AxoGen Inc
NASDAQ:AXGN
|
Selling, General & Administrative
-$117.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-21%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Selling, General & Administrative
-$4.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Selling, General & Administrative
-$5.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
Stryker Corp
NYSE:SYK
|
Selling, General & Administrative
-$7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
Abbott Laboratories
NYSE:ABT
|
Selling, General & Administrative
-$11.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Selling, General & Administrative
-$2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-12%
|
See Also
What is AxoGen Inc's Selling, General & Administrative?
Selling, General & Administrative
-117.9m
USD
Based on the financial report for Mar 31, 2024, AxoGen Inc's Selling, General & Administrative amounts to -117.9m USD.
What is AxoGen Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-21%
Over the last year, the Selling, General & Administrative growth was -4%. The average annual Selling, General & Administrative growth rates for AxoGen Inc have been -7% over the past three years , -6% over the past five years , and -21% over the past ten years .